Abstract
The biological phenomenon of cell fusion plays an important role in several physiological processes, like fertilization, placentation, or wound healing/tissue regeneration, as well as pathophysiological processes, such as cancer. Despite this fact, considerably less is still known about the factors and conditions that will induce the merging of two plasma membranes. Inflammation and proliferation has been suggested as a positive trigger for cell fusion, but it remains unclear, which of the factor(s) of the inflamed microenvironment are being involved. To clarify this we developed a reliable assay to quantify the in vitro fusion frequency of cells using a fluorescence double reporter vector (pFDR) containing a LoxP-flanked HcRed/DsRed expression cassette followed by an EGFP expression cassette. Because cell fusion has been implicated in cancer progression four human breast cancer cell lines were stably transfected with a pFDR vector and were co-cultured with the stably Cre-expressing human breast epithelial cell line. Cell fusion is associated with a Cre-mediated recombination resulting in induction of EGFP expression in hybrid cells, which can be quantified by flow cytometry. By testing a panel of different cytokines, chemokines, growth factors and other compounds, including exosomes, under normoxic and hypoxic conditions our data indicate that the proinflammatory cytokine TNF-α together with hypoxia is a strong inducer of cell fusion in human MDA-MB-435 and MDA-MB-231 breast cancer cells.
Similar content being viewed by others
References
Dittmar T (2002) Modern technologies in immune diagnosis. Infect Immun Pharmacol 1–2:17–19
Dittmar T, Zänker KS (2011) Cell fusion in health and disease, vol 1. Adv Exp Med Biol. Springer, Dordrecht
Dittmar T, Zänker KS (2011) Cell fusion in health and disease, vol 2. Adv Exp Med Biol. Springer, Dordrecht
Perez-Vargas J, Krey T, Valansi C, Avinoam O, Haouz A, Jamin M, Raveh-Barak H, Podbilewicz B, Rey FA (2014) Structural basis of eukaryotic cell–cell fusion. Cell 157(2):407–419. doi:10.1016/j.cell.2014.02.020
Huppertz B, Bartz C, Kokozidou M (2006) Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron 37(6):509–517
Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, Keith JC Jr, McCoy JM (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403(6771):785–789
Podbilewicz B (2014) Virus and cell fusion mechanisms. Annu Rev Cell Dev Biol 30:111–139. doi:10.1146/annurev-cellbio-101512-122422
Cornelis G, Heidmann O, Bernard-Stoecklin S, Reynaud K, Veron G, Mulot B, Dupressoir A, Heidmann T (2012) Ancestral capture of syncytin-Car1, a fusogenic endogenous retroviral envelope gene involved in placentation and conserved in Carnivora. Proc Natl Acad Sci USA 109(7):E432–441. doi:10.1073/pnas.1115346109
Aguilar PS, Baylies MK, Fleissner A, Helming L, Inoue N, Podbilewicz B, Wang H, Wong M (2013) Genetic basis of cell–cell fusion mechanisms. Trends Genet 29(7):427–437. doi:10.1016/j.tig.2013.01.011
Zhou X, Platt JL (2011) Molecular and cellular mechanisms of mammalian cell fusion. Adv Exp Med Biol 713:33–64. doi:10.1007/978-94-007-0763-4_4
Alvarez-Dolado M, Martinez-Losa M (2011) Cell fusion and tissue regeneration. Adv Exp Med Biol 713:161–175. doi:10.1007/978-94-007-0763-4_10
Kozorovitskiy Y, Gould E (2003) Stem cell fusion in the brain. Nat Cell Biol 5(11):952–954
Vassilopoulos G, Russell DW (2003) Cell fusion: an alternative to stem cell plasticity and its therapeutic implications. Curr Opin Genet Dev 13(5):480–485
Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M (2003) Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422(6934):897–901
Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M (2004) Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 10(7):744–748
Davies PS, Powell AE, Swain JR, Wong MH (2009) Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS ONE 4(8):e6530. doi:10.1371/journal.pone.0006530
Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel SY, Steinman L, Rossi FM, Blau HM (2008) Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol 10(5):575–583
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545. doi:10.1016/S0140-6736(00)04046-0
Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315(26):1650–1659
Dittmar T, Nagler C, Niggemann B, Zänker KS (2013) The dark side of stem cells: triggering cancer progression by cell fusion. Curr Mol Med 13(5):735–750
Duelli D, Lazebnik Y (2003) Cell fusion: a hidden enemy? Cancer Cell 3(5):445–448
Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, Platt J, Bermudes D, Pawelek J (1998) Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16(4):299–312
Lu X, Kang Y (2009) Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci USA 106(23):9385–9390
Xu MH, Gao X, Luo D, Zhou XD, Xiong W, Liu GX (2014) EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PLoS ONE 9(2):e87893. doi:10.1371/journal.pone.0087893
Miller FR, Mohamed AN, McEachern D (1989) Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res 49(15):4316–4321
Dittmar T, Schwitalla S, Seidel J, Haverkampf S, Reith G, Meyer-Staeckling S, Brandt BH, Niggemann B, Zanker KS (2011) Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin Exp Metastasis 28(1):75–90
Carloni V, Mazzocca A, Mello T, Galli A, Capaccioli S (2013) Cell fusion promotes chemoresistance in metastatic colon carcinoma. Oncogene 32(21):2649–2660. doi:10.1038/onc.2012.268
Dittmar T, Nagler C, Schwitalla S, Reith G, Niggemann B, Zanker KS (2009) Recurrence cancer stem cells—made by cell fusion? Med Hypotheses 73(4):542–547
Chang CC, Sun W, Cruz A, Saitoh M, Tai MH, Trosko JE (2001) A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Radiat Res 155(1 Pt 2):201–207
Nolden L, Edenhofer F, Haupt S, Koch P, Wunderlich FT, Siemen H, Brustle O (2006) Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods 3(6):461–467. doi:10.1038/nmeth884
Somers A, Jean JC, Sommer CA, Omari A, Ford CC, Mills JA, Ying L, Sommer AG, Jean JM, Smith BW, Lafyatis R, Demierre MF, Weiss DJ, French DL, Gadue P, Murphy GJ, Mostoslavsky G, Kotton DN (2010) Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28(10):1728–1740. doi:10.1002/stem.495
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Koenen P, Spanholtz TA, Maegele M, Sturmer E, Brockamp T, Neugebauer E, Thamm OC (2015) Acute and chronic wound fluids inversely influence adipose-derived stem cell function: molecular insights into impaired wound healing. Int Wound J 12(1):10–16. doi:10.1111/iwj.12039
Voss MJ, Moller MF, Powe DG, Niggemann B, Zanker KS, Entschladen F (2011) Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism. BMC Cancer 11:158. doi:10.1186/1471-2407-11-158
Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425(6961):968–973
Sprangers AJ, Freeman BT, Kouris NA, Ogle BM (2012) A Cre-Lox P recombination approach for the detection of cell fusion in vivo. J Vis Exp 59:e3581. doi:10.3791/3581
Heyder C, Gloria-Maercker E, Hatzmann W, Zänker KS, Dittmar T (2006) Circulating cancer cells: Flow cytometry, video microscopy and confocal laser scanning microscopy. In: Hayat MA (ed) Handbook of immunohistochemistry and in situ hybridization of human carcinomas, vol 4., Molecular genetics, gastrointestinal carcinoma, and ovarian carcinoma, vol 4Elsevier Academic Press, Burlington, pp 77–88
Record M (2014) Intercellular communication by exosomes in placenta: a possible role in cell fusion? Placenta 35(5):297–302. doi:10.1016/j.placenta.2014.02.009
Sinkovics JG (2011) Horizontal gene transfers with or without cell fusions in all categories of the living matter. Adv Exp Med Biol 714:5–89. doi:10.1007/978-94-007-0782-5_2
Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5(11):899–904
Yan B, Wang H, Li F, Li CY (2006) Regulation of mammalian horizontal gene transfer by apoptotic DNA fragmentation. Br J Cancer 95(12):1696–1700. doi:10.1038/sj.bjc.6603484
Bergsmedh A, Szeles A, Henriksson M, Bratt A, Folkman MJ, Spetz AL, Holmgren L (2001) Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci USA 98(11):6407–6411
Bergsmedh A, Ehnfors J, Spetz AL, Holmgren L (2007) A Cre-loxP based system for studying horizontal gene transfer. FEBS Lett 581(16):2943–2946. doi:10.1016/j.febslet.2007.05.045
Nagler C, Hardt C, Zänker KS, Dittmar T (2011) Co-cultivation of murine BMDCs with 67NR mouse mammary carcinoma cells give rise to highly drug resistant hybrid cells. Cancer Cell Int 11:21
Trejo-Becerril C, Perez-Cardenas E, Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velazquez LA, Hidalgo-Miranda A, Perez-Montiel D, Chavez-Blanco A, Cruz-Velazquez J, Diaz-Chavez J, Gaxiola M, Duenas-Gonzalez A (2012) Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS ONE 7(12):e52754. doi:10.1371/journal.pone.0052754
Ehnfors J, Kost-Alimova M, Persson NL, Bergsmedh A, Castro J, Levchenko-Tegnebratt T, Yang L, Panaretakis T, Holmgren L (2009) Horizontal transfer of tumor DNA to endothelial cells in vivo. Cell Death Differ 16(5):749–757. doi:10.1038/cdd.2009.7
Ozel C, Seidel J, Meyer-Staeckling S, Brandt BH, Niggemann B, Zanker KS, Dittmar T (2012) Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk. Cell Commun Signal 10(1):10. doi:10.1186/1478-811X-10-10
Sumida GM, Yamada S (2013) Self-contact elimination by membrane fusion. Proc Natl Acad Sci USA 110(47):18958–18963. doi:10.1073/pnas.1311135110
Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD (2007) IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. In: J Leukoc Biol, vol 82. United States, pp 1542–1553. doi:10.1189/jlb.0107058
Helming L, Gordon S (2009) Molecular mediators of macrophage fusion. Trends Cell Biol 19:514–522. doi:10.1016/j.tcb.2009.07.005
Helming L, Tomasello E, Kyriakides TR, Martinez FO, Takai T, Gordon S, Vivier E (2008) Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal 1:ra11. doi:10.1126/scisignal.1159665
Shabo I, Olsson H, Stal O, Svanvik J (2013) Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival. Clin Breast Cancer 13(5):371–377. doi:10.1016/j.clbc.2013.05.003
Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J (1994) Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 10(2):148–153
Wu Y, Zhou BP (2010) TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. In: Br J Cancer, vol 102. England, pp 639–644. doi:10.1038/sj.bjc.6605530
Kim S, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE (2008) Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. In: Molecules, vol 13. Switzerland, pp 2975–2985. doi:10.3390/molecules13122975
Skokos EA, Charokopos A, Khan K, Wanjala J, Kyriakides TR (2011) Lack of TNF-alpha-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. In: Am J Pathol, vol 178, United States, pp 2311–2321. doi:10.1016/j.ajpath.2011.01.045
Ma L, Lan F, Zheng Z, Xie F, Wang L, Liu W, Han J, Zheng F, Xie Y, Huang Q (2012) Epidermal growth factor (EGF) and interleukin (IL)-1beta synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion. In: Mol Cancer, vol 11, England, p 79. doi:10.1186/1476-4598-11-79
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867
Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364(7):656–665. doi:10.1056/NEJMra0910283
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444. doi:10.1038/nature07205
Tang ZN, Zhang F, Tang P, Qi XW, Jiang J (2011) Hypoxia induces RANK and RANKL expression by activating HIF-1alpha in breast cancer cells. In: Biochem Biophys Res Commun, vol 408, United States, pp 411–416. doi:10.1016/j.bbrc.2011.04.035
Tang ZN, Zhang F, Tang P, Qi XW, Jiang J (2011) RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation. Oncol Rep 26(5):1243–1250. doi:10.3892/or.2011.1368
Yu M, Qi X, Moreno JL, Farber DL, Keegan AD (2011) NF-kappaB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-kappaB pathways. J Immunol, vol 187, United States, pp 1797–1806. doi:10.4049/jimmunol.1002628
Acknowledgments
We would like to thank Dr. Oliver Thamm (Clinic for Plastic- and Reconstructive Surgery, Handsurgery, Burn Care Center, University of Witten/Herdecke, Cologne-Merheim Medical Center, Cologne, Germany) for providing us with chronic wound fluid (CWF). This work was supported by the Fritz-Bender-Foundation, Munich, Germany.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary data 1
These tables summarize the tested compounds, including concentration, and conditions, used in this study for each cell line. The relative fold change was calculated as described in the Material & Methods section. Shown are the mean ± STD of at least three independent experiments (DOC 335 kb)
Supplementary data 2
In this figure the relative fold changes in the amount of cell debris, also containing apoptotic bodies, of the compounds and conditions, which led to an increased number of green fluorescing cells are summarized. The amount of cell debris/apoptotic bodies was determined by gating the population located in the lower left corner of a FSC-H/SSC-H dot plot diagram. Shown are the mean ± STD of at least three independent experiments (TIFF 633 kb)
Rights and permissions
About this article
Cite this article
Mohr, M., Tosun, S., Arnold, W.H. et al. Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a Cre-LoxP-based double fluorescence reporter system. Cell. Mol. Life Sci. 72, 3769–3782 (2015). https://doi.org/10.1007/s00018-015-1910-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-015-1910-6